In order to rule out cancer safely!
With HT Vista® we present the first non-invasive device to support an early screening of lumps and bumps in dogs.
Using powerful Heat Diffusion Imaging (HDI) technology and an Artificial Intelligence algorithm, cancer in subcutaneous and dermal masses can be ruled out in a matter of minutes.
Subclassification of tumors: In cases where HT Vista detects a very low or very high probability of malignancy, benign tumors such as lipomas or malignant tumors such as mast cell tumors can be diagnosed. This avoids unnecessary invasive procedures for lipomas and detects mast cell tumors at an early stage.
Cancer screening with HT Vista®
Cancer is the most common cause of death in dogs.
1/3 of tumors are located on or under the skin. Unfortunately, many lumps or bumps are still not examined in detail today.
Early screening is the most important and effective step in cancer treatment.
Did you know that...
- 40% of masses are not even sampled.
- 20% of cytology samples are non-diagnostic.
- 30% of dogs have more than one mass.
- Many samples need external laboratory.
- More than 80% from 1'000 masses of the study findings with HT Vista were not malignant.
Cancer screening with HT Vista®
HT Vista® is an innovative system that uses a new patented imaging technology and Artificial Intelligence to simplify the early examination of cutaneous and subdermal masses.
With the non-invasive system, more cases can be painlessly screened directly in the veterinary practice to safely rule out cancer on the spot in a few minutes only!
Cancer detection with screening and diagnostic functions.
Advances in artificial intelligence and the steadily growing number of now almost 1,200 validated masses have made it possible to program two new exciting functions:
Cancer Risk Values and Levels: These offer a visual framework to help veterinary teams assess lumps and bumps on the spot, aiding in decision-making by accurately identifying low-risk cases that can be confidently monitored, while guiding next steps for moderate- and high-risk cases.
Screening results are based on a Sensitivity (Sen) of 90% and a Negative Predictive Value (NPV) of 98%, presented as a Cancer Risk based on malignant probability.
Low risk: Malignant Probability ≤10%
Moderate Cancer Risk- Malignant Probability 11%-49%
High Cancer Risk- Malignant Probability ≥50%
Zum vollständigen Artikel -> HT Vista 4.0: Introducing HT Vista’s New Diagnostic Capability
Advantages of cancer screening with HT Vista
Direct at your point of care
On-site examination by assistants, fast even for secondary findings.
Non-invasive
A stress, risk and pain free experience for the patient and owner.
Affordable
Cost-efficient screening to supplement preventive services.
Result in a few minutes
The immediate result makes it easier to take the next steps with the pet owner.
98% Negative Predictive Value (NPV) in avg.
90% Sensitivity
Easy to use
Quick to learn and portable system for veterinary staff.
A unique new technology
HT Vista® from HTVet is the first AI-driven non-invasive screening tool that allows veterinarians and nurses to rule out cancer in subcutaneous and dermal masses thanks to powerful Heat Diffusion Imaging (HDI) technology.
This innovative patented imaging modality relies on unique thermal signals that differ between normal and malignant tissues, as they are recorded by the device, during a rapid heating and cooling process.
Using artificial intelligence, the algorithm compares the patient's signal with previously learned signals and calculates the probability of malignancy.
The algorithm is constantly being improved through continuous training and the validated results of almost 1’200 dogs.
On the web page of HTVet you will find the latest international press releases and interviews.
Result in few minutes
Registration
Examination of masses and registration of the new patient in the system.
Preparation scan
Trimming of the affected areas using a shaver / clipper.
Scanning
Scan all affected areas and upload to the HTVet Cloud.
Screening and diagnosis
Analysis using artificial intelligence for malignancy and most prevalent tumor types.
Result in a few minutes
Receipt of the result within a few minutes on the HT Vista system and by mail.
Next steps
Discussion of the result and further measures with the animal owner.
Result available 5-10 minutes after the scan!
Testimonials
We now use the device to screen every cutaneous or subcutaneous lump that we see in our canine patients prior to obtaining an aspirate. We have seen the greatest impact in patients with multiple, long-standing skin masses where owners can be reluctant to aspirate or biopsy multiple lesions and are more concerned about the risk of GA or sedation. The non-invasive nature of the HT Vista is much more appealing to pet owners and gives a quick result within minutes! In addition, the algorithm and AI is constantly evolving and learning from the samples that are taken and so I am confident the scanner will offer more features in the future!"
Development and manufacturing
HT Vista® was developed together with veterinary oncologists and specialists in innovative imaging techniques and artificial intelligence. The algorithms for analyzing cutaneous and subcutaneous masses are continuously trained and developed further.
The system is developed and manufactured according to medical technology guidelines and is approved for veterinary medicine.
It is imported, controlled and trained by P12 Medical in Switzerland. All regulatory requirements of Switzerland and the EU are fulfilled by the system.